Overview

A Post-Exposure Prophylaxis Study of PF-07321332/Ritonavir in Adult Household Contacts of an Individual With Symptomatic COVID-19

Status:
Recruiting

Trial end date:
2021-12-25

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the efficacy and safety of PF-07321332/ritonavir as postexposure prophylaxis for adult household contacts of a patient with COVID-19

Phase:

Phase 3

Details

Lead Sponsor:

Pfizer

Treatments:

Ritonavir